Finally, Valeant had some decent news and the stock is going off like a rocket
Advertisement
Thomson Reuters
Advertisement
The ad-hoc committee says that it found no more issues with the company's accounting beyond the $58 million misstatement that has forced it to delay its annual report.
The stock is up 17% in Tuesday's pre-market trading session.
Valeant's stock has been dogged since October, when accusations from a short seller and government scrutiny cast light on a previously undisclosed part of its business, a shady specialty pharmacy that it used to distribute drugs called Philidor.
Philidor was shut down in January, but the accounting issues it raised remained.
Advertisement
Advertisement
- A centenarian who starts her day with gentle exercise and loves walks shares 5 longevity tips, including staying single
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Having an regional accent can be bad for your interviews, especially an Indian one: study
- Dirty laundry? Major clothing companies like Zara and H&M under scrutiny for allegedly fuelling deforestation in Brazil
- 5 Best places to visit near Darjeeling
- Climate change could become main driver of biodiversity decline by mid-century: Study
- RBI initiates transition plan: Small finance banks to ascend to universal banking status
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market